Thursday, April 03, 2025
$12.75M MPower Grant to Spur Biomedical Tech Advances at 4MLK
A new five-year, $12.75 million grant from the University of Maryland Strategic Partnership: MPowering the State (MPower) aims to accelerate breakthroughs in biomedical technology and innovations through a collaboration between the University of Maryland, College Park (UMCP) and the University of Maryland, Baltimore (UMB).
Thursday, April 03, 2025
Researchers identify “master regulator” gene that could lead to more effective treatment for patients with ovarian cancer
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.
Wednesday, April 02, 2025
Researchers Reveal Key Brain Differences to Explain Why Ritalin Helps Improve Focus in Some More Than Others
Nearly 16 million American adults have been diagnosed with attention deficit hyperactivity disorder (ADHD), but evidence suggests that more than 30 percent of them don’t respond well to stimulant medications like Ritalin and Adderall. A new clinical trial provides a surprising explanation for why this may be the case: There are individual differences in how our brains circuits are wired, including the chemical circuits responsible for memory and concentration, according to a new study co-led by the University of Maryland School of Medicine (UMSOM) and performed at the National Institutes of Health (NIH) Clinical Center.
Tuesday, March 25, 2025
Internationally Recognized Vaccine Expert Dr. Paul Offit to Deliver Graduation Address to the University of Maryland School of Medicine’s 216th Graduating Class
Leading vaccine advocate Paul Offit, MD, an internationally recognized immunologist and virologist, will deliver the keynote address for this year’s graduating medical student class. He is best known as co-inventor of the rotavirus vaccine, RotaTeq, which is universally recommended for infants by the CDC and has been credited for saving hundreds of lives every day.
Monday, March 24, 2025
Susan Kinter Named as New President and CEO of the Maryland Medicine Comprehensive Insurance Program
Susan Kinter, BSN, JD, stepped into her new role at MMCIP on February 24 after serving in successive executive roles at the organization since 1998. In her new role, she will guide MMCIP in its core missions to ensure physician, staff, and patient safety across all the University of Maryland system member organizations and practice groups, as well as administering the Health Professional Liability Insurance Program for physicians and nurses.
Thursday, March 13, 2025
UMSOM Rising Third-Year Medical Students Celebrate Transition to Clinical Care Training at Annual Student Clinician Ceremony
The University of Maryland School of Medicine (UMSOM) celebrated 165 rising third-year medical students at the Annual Student Clinician Ceremony on March 4, as they prepare to begin their clinical care training. Over the next two years, students will transition from the classroom to the bedside to gain experience seeing patients through a wide variety of specialties within local healthcare organizations.
Wednesday, March 12, 2025
Meningococcal Vaccine Found to be Safe and Effective for Infants in Sub-Saharan Africa
University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age. This study provided evidence that formed the basis for the World Health Organization’s (WHO) decision last year to recommend the pentavalent Men5CV meningitis vaccine for infants ages 9 months and older.
Tuesday, March 11, 2025
First ever UMSOM "Shark Tank" competition for biomedical research awards $120,000 for innovative faculty projects
The members of the University of Maryland School of Medicine (UMSOM) Board of Visitors (BOV) regularly serve as advisors to the school on strategic planning, fundraising, and philanthropy. But on December 17, the Board members took on a new role for the very first time — they became “sharks.”
Tuesday, March 04, 2025
In Memoriam: Dr. Joseph S. McLaughlin
Dr. Joseph S. McLaughlin had a distinguished and longstanding affiliation with the University of Maryland School of Medicine (UM SOM) and the University of Maryland Medical Center (UMMC) spanning 66 years. His profound impact on medical education, patient care, and surgical innovation leaves a lasting legacy at the University of Maryland.
Wednesday, February 26, 2025
Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research Suggests
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.
Friday, February 21, 2025
UM School of Medicine Dermatology Researchers Discover New Skin Disease Using Innovative Diagnostic Platform
A significant number of Americans experience chronic inflammatory skin conditions with no pinpointed cause and often no effective treatments beyond symptom management. Now a new study could pave the way for precision-medicine based diagnostic testing and targeted treatment.
Wednesday, February 19, 2025
UM Greenebaum Comprehensive Cancer Center Executive Director, Taofeek K. Owonikoko, MD, PhD, named one of the 25 Black Marylanders to Watch by The Baltimore Sun
Taofeek K. Owonikoko, MD, PhD, Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), has been named one of the 25 Black Marylanders to Watch for 2025 by The Baltimore Sun.
Friday, February 07, 2025
UM School of Medicine Surgeon-Scientist to Co-Lead Large International Clinical Trial to Determine Most Effective Treatment for Common Hip Fracture in Older Adults
Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic surgeons have repaired a common fracture of the upper part of the thigh bone, or femur, near the hip using screws and plates to piece together slightly separated pieces of bone. But many surgeons now treat these “minimally displaced” femoral neck fractures by replacing the hip joint with a metal implant.
Wednesday, February 05, 2025
Two UM School of Medicine Faculty Appointed as 2025 MPower Professors
The University of Maryland Strategic Partnership: MPowering the State (MPower) today announced the appointment of seven professors from the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) as 2025 MPower Professors.
Wednesday, January 15, 2025
University of Maryland, Baltimore and Wexford Science & Technology Cut Ribbon on 4MLK Building
The University of Maryland, Baltimore (UMB) and Wexford Science & Technology, LLC, celebrated the grand opening of 4MLK, the newest addition to the University of Maryland BioPark, with a ribbon-cutting ceremony. The event brought together distinguished guests, including Lieutenant Governor Aruna Miller and Mayor Brandon Scott, alongside University and Wexford leaders, neighborhood representatives, innovation community members, economic development officials, and BioPark tenants.
Wednesday, January 15, 2025
Jeremy L. Davis, MD, Named UMGCCC Surgical Oncology Lead and Chief of the Division of Surgical Oncology at UMSOM
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) Executive Director, Taofeek K. Owonikoko, MD, PhD, and University of Maryland School of Medicine (UMSOM) Department of Surgery Chair, Christine Lau, MD, MBA, have announced that Jeremy L. Davis, MD, will serve as the new Surgical Oncology Lead for UMGCCC and Chief of the Division of Surgical Oncology in the Department of Surgery at UMSOM. Dr. Davis is a nationally recognized surgical oncologist and leader in gastric cancer research.
Tuesday, January 14, 2025
University of Maryland, Baltimore and University of Maryland, College Park Announce $10 Million Joint Gift from Edward and Jennifer St. John and the Edward St. John Foundation for New Center for Translational Engineering and Medicine
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) are pleased to announce a $10 million joint gift from Edward and Jennifer St. John and the Edward St. John Foundation. This landmark investment will launch the Edward & Jennifer St. John Center for Translational Engineering and Medicine (CTEM), a collaboration between the University of Maryland School of Medicine (UMSOM) at UMB and the A. James Clark School of Engineering at UMCP. Together, researchers from these distinct disciplines will tackle a broad spectrum of generational health challenges and drive medical innovations that benefit patients in Maryland and beyond.
Monday, January 13, 2025
UMMS Rolls Out Virtual 'NEST' to Support Bedside Care Teams in Labor and Delivery Units Across the System
The University of Maryland Medical System (UMMS) has launched NEST (Neonatal Outcomes Impacted by Escalation Safety Telemetry), a groundbreaking remote fetal monitoring center that offers continuous, real-time monitoring of critical elements of labor and delivery across System hospitals. NEST is led by a medical director and team of highly specialized nurses who bring more than 200 years of combined experience in safely delivering thousands of babies.
Wednesday, January 08, 2025
Presenting a Path Forward for Future Genetically-Modified Pig Heart Transplants: Lessons Learned from Second Patient
Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in the world to receive a genetically-modified pig organ. Lawrence Faucette, 58, received a pig heart at the University of Maryland Medical Center in 2023 to treat his end-stage heart failure. He lived for 40 days before choosing to forgo additional treatment after the transplant began to fail due to rejection.
Sunday, January 05, 2025
Medical Student Researchers Win Recognition at 47th Annual UMSOM Medical Student Research Day event
On November 12 and 13, the University of Maryland School of Medicine (UMSOM) hosted the 46th annual Medical Student Research Day), where more than 140 UMSOM students presented posters on their research in basic, clinical, translational, and population sciences. Jointly sponsored by the UMSOM Chapter of the Alpha Omega Alpha Honor Society and the Office of Student Research in the Dean’s Office, the event marked an opportunity for medical students to both exhibit their research before expert faculty judges and learn from working physician-scientists how to balance research alongside clinical practice.